Stay updated with breaking news from Marc Hertz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FRENCHTOWN, NJ / ACCESSWIRE / May 23, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced that Marc Hertz, PhD, Chief Executive Officer of
GRI Bio (NASDAQ:GRI) CEO Marc Hertz joined Steve Darling from Proactive to share news the company has begun patient enrollment in a Phase 2a biomarker study...
Findings demonstrate that the number of NKT cells positively correlates with the number of airway macrophages in IPF patients GRI...
Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseasesOn track to launch a Phase 2a biomark...